View Press Releases
-
CD Formulation Demonstrates Expertise in CAR-T and CAR-NK Cell Development for Drug Delivery Systems
-
Daptomycin ReadyMade™ Solution to Power Up Spectrum and Microbiology Applications
-
Verdot expands offering with FlexiPro™ TFF system to meet growing industry demand
Leading downstream bioprocessing technology company, Verdot, announces the launch of its FlexiPro™ TFF, a multipurpose tangential flow filtration (TFF) GMP system, in response to rising industry demand for gene therapy, vaccine, and mRNA-based therapeutics.
Sep 17, 2023
-
Samsung Biologics announces expanded strategic agreement with Bristol Myers Squibb to manufacture an antibody cancer drug substance
-
Custom Stainless Enclosures Highlights 4Xxtreme® Double Seal Enclosures™
-
Invitation to learn from the best: Evening of insights and networking will honor a clinical data management stalwart
Invitation to learn from the best: Evening of insights and networking will honor a clinical data management stalwart Prof Deborah Ashby to give the 2023 Sally Hollis Memorial Lecture in Macclesfield
Sep 12, 2023
-
BRIM closes a $45.8 million rights issue early to accelerate its pipeline of regenerative peptides
BRIM Biotechnology, Inc. (“BRIM,” TPEx 6885), a clinical-stage biotechnology company focusing on developing regenerative peptides for ophthalmology and degenerative joint diseases, announced today that 22,500 shares have been issued at a premium of NT$65 (~US$2.03), raising a total of NT$1.4625 billion (~US$45.8 million). The rights issue was fully paid on 31st August 2023, four days early compared to the scheduled date of 4th September.
Sep 12, 2023
-
Torx® Software announces global drug discovery collaboration with CDD Vault®
Torx® Software Limited has launched a major international collaboration with CDD Vault, which will create a shared digital ecosystem for drug discovery data
Sep 12, 2023
-
SMi Systems secures UK patent for breakthrough single molecule imaging capabilities
SMi Systems has secured a patent from the UK Intellectual Property Office for the single-molecule imaging technologies that underpin its super-resolution multi-omic platform.
Sep 13, 2023
-
Central California Alliance for Health Selects ZeOmega’s Care Management Solution to Support Whole-Person Care
Central California Alliance for Health (CCAH), just announced they selected ZeOmega’s care management solution to support its 420,000+ Medi-Cal members, including those in the most vulnerable communities. ZeOmega’s platform will enable CCAH to pinpoint the care needs of at-risk members and champion CalAIM’s efforts to provide equitable, person-centered care across California. This partnership also reflects the increased demand for flexible and scalable technology solutions to support government-sponsored healthcare programs across the nation.
Sep 13, 2023
-
New Cell & Gene Therapy Solutions from Form Bio Analyze Billions of Potential Construct Candidates, Reducing Time-to-Clinic
Form Bio, the provider of advanced computational life sciences technology announced today capabilities for cell and gene therapy companies to rapidly model billions of potential construct candidates. With great progress to date but headwinds around safety and manufacturability, Form’s new solutions help therapy developers find the safest and highest yielding versions of their therapies.
Sep 13, 2023
-
Huateng Pharma to Attend CPHI Barcelona 2023
Huateng Pharma will be attending CPhI Worldwide, Booth 3C02, Hall 3.
Sep 14, 2023
-
Launch of high-quality (pre-clinical) enzymes suitable for pre-clinical and process development in mRNA vaccine and therapeutics
Takara Bio Europe has announced the launch of new high-quality grade mRNA production enzymes suitable for pre-clinical and process development in mRNA vaccine and therapeutic manufacturing.
Sep 11, 2023
-
Lonza Upgrades MODA-ES® Module for Enhanced Electronic Batch Record Execution
Lonza has released the MODA-ES® Module v4.0, an upgrade to its electronic batch record (EBR) module that enhances user experience and simplifies integration to expedite product release.
Sep 10, 2023
-
GenNext Unveils the World’s First Fully Automated Protein Footprinting System at the California Separation Science Society Meeting
GenNext Unveils the World’s First Fully Automated Protein Footprinting System at the California Separation Science Society Meeting The new AutoFox™ System promises to deliver hands-free, high-throughput Hydroxyl Radical Protein Footprinting for sophisticated Higher Order Structural (HOS) analysis
Sep 4, 2023
-
GenNext & SCIEX to Co-Market an Advanced High Order Structure Analysis (HOS) Workflow for Biopharmaceutical Research
GenNext & SCIEX Co-Market an advanced high order structure analysis workflow for biopharmaceutical research to spread the adoption of the latest HOS and Mass Spec technologies to help scientists improve the safety, stability, and effectiveness of biotherapeutics
Sep 4, 2023
-
AVIA’s National Generative AI Collaborative Announces New Experts, Enhanced Health System Participation
The Generative AI Strategic Collaborative reveals a slate of 10 clinical, ethics, technology, and regulatory experts for its national consortium
Sep 6, 2023
-
BioIVT Completes XenoTech Integration, Highlights Expanded ADME-Tox Research Services at the North American ISSX Meeting
BioIVT has implemented new tiered ‘fit-for-purpose’ study designs for metabolism, drug-drug interaction, and transporter programs, which utilize their electronic notebook system and automated reports, enabling them to better meet clients’ needs by reducing turnaround time, while maintaining the highest level of scientific expertise and quality.
Sep 6, 2023
-
Amerigo Scientific Releases FSB Solution Products to Expedite Alzheimer’s Disease Research
-
Intellegens and CPI awarded £1.6m Innovate UK grant to advance manufacture of oligonucleotide therapeutics with machine learning
Intellegens, a company applying machine learning (ML) to accelerate innovation in R&D, has secured a £1.6m grant from Innovate UK, part of UK Research and Innovation (UKRI), to apply ML in the emerging field of oligonucleotide therapies. In collaboration with the Centre for Process Innovation (CPI), the two-year project will augment and validate the company’s ML technology, Alchemite™, as a tool to enhance productivity and yields of oligonucleotide therapeutic manufacture through performance prediction and optimisation of quality control strategies.
Aug 29, 2023